Elevated Plasma Homocysteine Level Increased the Risk of Early Renal Impairment in Acute Ischemic Stroke Patients

被引:0
作者
Jingjuan Chen
Guode Li
Zuohang Xu
Chengguo Zhang
Yukai Wang
Haiqun Xie
Yan Shao
Lingmei Peng
Jiancong Lu
Dahua Yuan
机构
[1] First People’s Hospital of Foshan,
来源
Cellular and Molecular Neurobiology | 2017年 / 37卷
关键词
Homocysteine; Cystatin C; Stroke; Glomerular filtration rate; Renal insufficiency;
D O I
暂无
中图分类号
学科分类号
摘要
Renal insufficiency is associated with the prognosis of acute ischemic stroke (AIS) and homocysteine (Hcy) levels. This study investigated the association between plasma Hcy levels and renal insufficiency in patients with AIS. A total of 987 patients with AIS who had been treated at the First People’s Hospital of Foshan between 2011 and 2014 were retrospectively studied. Based on their cystatin C (Cys C) levels, the patients were divided into the normal renal function group (Cys C ≤ 1.25 mg/L) or the renal impairment group (Cys C > 1.25 mg/L). Multivariate regression analysis was applied to reveal the association between hyperhomocysteinemia (HHcy) and renal impairment. The renal impairment group showed more advanced age of onset, higher percentage of prior stroke and hypertension, higher baseline National Institute of Health Stroke Scale score, lower high-density lipoprotein cholesterol levels, and higher Hcy levels compared with the normal renal function group. A multivariate analysis revealed a relationship between early renal impairment and Hcy levels: an increase of Hcy by 1 μmol/L was associated with an increase of 12–18% of the risk of renal impairment among patients with AIS and HHcy. Patients with AIS and HHcy had a 2.42–3.51 fold increase of the risk of renal impairment compared with patients with normal Hcy level (P < 0.001). In conclusion, patients with stroke and HHcy could be more prone to renal impairment.
引用
收藏
页码:1399 / 1405
页数:6
相关论文
共 61 条
[1]  
Brattstrom L(2000)Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72 315-323
[2]  
Wilcken DE(2010)Editor team on treatment guidelines of acute ischemic stroke from Cerebrovascular Diseases Study Group in neurology branch of Chinese Medical Association. China acute ischemic stroke treatment guidelines J Neurol 43 146-153
[3]  
Coll E(2000)Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment Am J Kidney Dis 36 29-34
[4]  
Cui R(2008)Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study Atherosclerosis 198 412-418
[5]  
Gensicke H(2013)IV thrombolysis and renal function Neurology 81 1780-1788
[6]  
Graham IM(1997)Plasma homocysteine as a risk factor for vascular disease The European Concerted Action Project JAMA 277 1775-1781
[7]  
Han H(2001)Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine J Ren Nutr 11 149-154
[8]  
Helmersson-Karlqvist J(2014)Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort Atherosclerosis 234 108-113
[9]  
Arnlov J(2002)Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2015-2022
[10]  
Carlsson AC(2015)Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial JAMA 313 1325-1335